Raised CRP levels in obese patients: Symptoms of depression have an independent positive association

Obesity

Volumn 16, Issue 9, 2008, Pages 2010-2015

  Dixon, John B ^a,b   Hayden, Melissa J ^a   Lambert, Gavin W ^b   Dawood, Tye ^b   Anderson, Margaret L ^a   Dixon, Maureen E ^a   O'Brien, Paul E ^a  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; DEPRESSION; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; OBESITY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE;

ADOLESCENT; ADULT; AGED; C-REACTIVE PROTEIN; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; QUESTIONNAIRES; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 50649118072     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.271     Document Type: Article

References (31)

1. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996;93:1976-1980.
2. Ferketich AK, Schwartzbaum JA, Frid DJ, Moeschberger ML. Depression as an antecedent to heart disease among women and men in the NHANES I study. National Health and Nutrition Examination Survey. Arch Intern Med 2000;160:1261-1268.
3. Bunker SJ, Colquhoun DM, Esler MD et al. "Stress" and coronary heart disease: psychosocial risk factors. Med JAust 2003;178:272-276.
4. Rosengren A, Hawken S, Ounpuu S et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:953-962.
5. Alesci S, Martinez PE, Kelkar Set al. Major depression is associated with significant diurnal elevations in plasma IL-6 levels, a shift of its circadian rhythm, and loss of physiologic complexity in its secretion: clinical implications. J Clin Endocrinol Metab 2005;90:2522-2530.
6. Maes M, Meltzer HY, Bosmans E et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 1995;34:301-309.
7. Wong ML, Xie B, Beatini N et al. Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: a possible link between inflammatory cytokines and atherogenesis. Proc Natl Acad Sci USA 2000;97:8681-8686.
8. Dawood T, Lambert E, Barton D et al. Specific serotonin reuptake inhibition in major depressive disorder adversely affects novel markers of cardiac risk. Hypertens Res 2007;30:285-293.
9. von Kanel R, Hepp U, Kraemer B et al. Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. J Psychiatr Res 2006;41:744-752.
10. Liukkonen T, Silvennoinen-Kassinen S, Jokelainen J et al. The association between C-reactive protein levels and depression: results from the northern Finland 1966 birth cohort study. Biol Psychiatry 2006;60:825-830.
11. Blake GJ, Ridker PM. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 2002;252:283-294.
12. Pearson TA, Mensah GA, Alexander RW et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
13. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999;282:2131-2135.
14. Ladwig KH, Marten-Mittag B, Lowel H, Doring A, Koenig W. Influence of depressive mood on the association of CRP and obesity in 3205 middle aged healthy men. Brain Behav Immun 2003;17:268-275.
15. Cardiovascular Risk in Young Finns Study; Elovainio M, Keltikangas-Jarvinen L et a/. Depressive symptoms and C-reactive protein: the Cardiovascular Risk in Young Finns Study. Psycho) Med 2006;36:797-805.
16. Straznicky NE, Lambert EA, Lambert GW et al. Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. J Clin Endocrinol Metab 2005;90:5998-6005.
17. Guilleminault C, Kirisoglu C, Ohayon MM. C-reactive protein and sleepdisordered breathing. Sleep 2004;27:1507-1511.
18. Dixon JB, Dixon ME, O'Brien PE. Depression in association with severe obesity: changes with weight loss. Arch Intern Med 2003;163:2058-2065.
19. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007;56:1010-1013.
20. Pontiroli AE, Pizzocri P, Librenti MC et al. Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab 2002;87:3555-3561.
21. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression. Guilford Press: New York, 1979.
22. Beck AT, Guth D, Steer RA, Ball R. Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behav Res Ther 1997;35:785-791.
23. Rothschild M, Peterson HR, Pfeifer MA. Depression in obese men. Int J Obes 1989;13:479-485.
24. Martinsen EW, Friis S, Hoffart A. Assessment of depression: comparison between Beck Depression Inventory and subscales of Comprehensive Psychopathological Rating Scale. Acta Psychiatr Scand 1995;92:460-463.
25. Lustman PJ, Clouse RE, Griffith LS, Carney RM, Freedland KE. Screening for depression in diabetes using the Beck Depression Inventory. Psychosom Med 1997;59:24-31.
26. Katz A, Nambi SS, Mather K et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-2410.
27. Ford DE, ErlingerTP. Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2004;164:1010-1014.
28. Kopp HP, Krzyzanowska K, Mohlig M et al. Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. Int J Obes Relat Metab Disord 2005;29:766-771.
29. Tchernof A, Nolan A, Sites CK, Ades PA, Poehlman ET. Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 2002;105:564-569.
30. Dixon JB, O'Brien PE. Changes in comorbidities and improvements in quality of life after LAP-BAND placement. Am J Surg 2002;184:51S-54S.
31. Tracey KJ. The inflammatory reflex. Nature 2002;420:853-859.